Thrombotic Microangiopathies

DBCOND0072350Anatomical Structures and FluidsCardiovascular Diseases

Thrombotic Microangiopathies is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Thrombotic Microangiopathy
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0533992ICD-10M31.1SNOMED CT126729006MedDRA10037562UMLSC0034155

What you can answer from here — as of October 23, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
32Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Boxed warningLabel boxed warnings that name this condition
Sign in
26Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Thrombotic Microangiopathies share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In